[Urothelial cancers from Endoxan].

A case of carcinoma of the bladder in a patient treated for 20 years with Endoxan is reported. The role of this drug in the aetiology of an urothelial carcinoma was appeared to be demonstrated by the 35 published cases in the literature and should lead to a limitation of its prescription and to regulate urological surveillance of patients receiving the agent.

Keywords

Adult, Male, Carcinoma, Transitional Cell, Tibia, Urinary Bladder Neoplasms, Cystitis, Humans, Bone Neoplasms, Sarcoma, Cyclophosphamide

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average